
    
      Oncological and overall outcome of the included patients are consecutively registrated at the
      out-patient clinic. At end of follow-up these survival data are analysed according to the
      presence of tumor cells in blood and bone marrow, and the prognostic impact of their presence
      are assessed.
    
  